Ruxolitinib Impurity Standards, USP related compounds
Ruxolitinib is in a class of medications called kinase inhibitors. Ruxolitinib is used to treat myelofibrosis (a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Ruxolitinib is also used to treat polycythemia vera in people who were not able to be treated successfully with hydroxyurea. Ruxolitinib is also used to treat acute graft versus host disease in adults and children 12 years of age and older who were treated unsuccessfully with steroid medications. Various Ruxolitinib related compounds or reference standards, listed on this page are needed in pharmaceutical research at the time to product development, ANDA filing or during production to study quality, stability, and genotoxicity study of Ruxolitinib related products.
Synthink is a most trusted source of Ruxolitinib Degradation Impurities, Ruxolitinib Genotoxic impurity, Ruxolitinib Process Impurities, USP related compounds, Ruxolitinib Nitrosamine impurity, N-Nitroso impurity etc. which are listed on this page.